Stone Paul A. 4
4 · IDEAYA Biosciences, Inc. · Filed Aug 18, 2023
Insider Transaction Report
Form 4
Stone Paul A.
SVP, General Counsel
Transactions
- Sale
Common Stock
2023-08-16$26.40/sh−100$2,640→ 19,103 total - Sale
Common Stock
2023-08-18$26.38/sh−3,822$100,820→ 15,281 total - Sale
Common Stock
2023-08-16$26.45/sh−100$2,645→ 19,203 total
Footnotes (2)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 27, 2023.
- [F2]This transaction was executed in multiple trades in prices ranging from $26.37 to $26.415, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.